NOTE: This activity is available only as part of a paid subscription series; it is not available for purchase as a single, stand-alone activity.
The goal of this program is to improve management of the metabolic side effects of antipsychotic agents in patients with schizophrenia. After hearing and assimilating this program, the clinicians will be better able to:
1. List risk factors for diabetes mellitus in patients with schizophrenia.
2. Explain appetite regulation and effects of antipsychotic drugs on weight gain.
3. Diagnose metabolic syndrome in patients with schizo¬phrenia using criteria from Adult Treatment Panel III.
4. Use lifestyle interventions for weight loss in patients with schizophrenia using antipsychotic drugs.
5. Employ metformin to control antipsychotic-associated weight gain.
- Provider:Lippincott Continuing Medical Education Institute, Inc.
- Activity Link: https://www.audio-digest.org/Specialties/Psychiatry
- Start Date: 2022-05-26 05:00:00
- End Date: 2022-05-26 05:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 1.75 hours
- Commercial Support: No
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: Yes
- Measured Outcome: Learner Competence, Learner Knowledge, Learner Performance
- Provider Ship: Directly Provided
- Registration: Open to all